30 /100
MEDIUM RISK
Score updated May 30, 2026

PIII — P3 Health Partners Inc. Dilution Risk Tracker

Track PIII dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PIII — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
65
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
30%
🔁 Convertible Conversion 60%
• Major convertible overhang: 7591% potential dilution
• Convertible risk score very high (85/100)
🔔 Track PIII — Get forecast alerts →

💹 Market Data

Market Cap$2.48B
Shares Outstanding3.33M
Float1.42M
Cash$25.01M
Debt$287.28M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 343.8K shares
#1 Alyeska Investment Group, L.p. 137.4K shares
#2 Vanguard Capital Management LLC 70.6K shares
#3 Trinity Financial Advisors LLC 27.1K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest283.5K
Days to Cover1.0
% of Float20.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
8-K 8K EVENT May 15, 2026
8-K 8K EVENT Apr 28, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track PIII Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PIII — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for PIII
📊 PIII FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PIII Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.